As of 30 Sep 2025, 4 institutional investors reported holding 193,779 shares of ITERUM THERAPEUTICS PLC SHS NEW - Stock (ITRM).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 193,779 | $129,831 | +$46,415 | $0.67 | 4 |
| 2025 Q2 | 87,613 | $87,175 | +$17,513 | $1.00 | 3 |
| 2025 Q1 | 70,013 | $86,116 | +$12,218 | $1.23 | 2 |
| 2024 Q4 | 60,045 | $106,280 | +$106,023 | $1.77 | 4 |
| 2024 Q3 | 145 | $158 | +$86 | $1.09 | 3 |
| 2024 Q2 | 66 | $76 | -$59 | $1.15 | 1 |
| 2024 Q1 | 104 | $161 | -$28 | $1.55 | 2 |
| 2023 Q4 | 104 | $205 | $0 | $1.97 | 2 |
| 2023 Q3 | 104 | $83 | $0 | $0.80 | 2 |
| 2023 Q2 | 104 | $112 | $0 | $1.08 | 2 |
| 2023 Q1 | 104 | $104 | -$196 | $1.00 | 2 |
| 2022 Q4 | 344 | $289 | -$168,723 | $0.84 | 3 |
| 2022 Q3 | 104,950 | $170,000 | -$3,224,173 | $1.65 | 3 |
| 2022 Q2 | 5,859,944 | $1,172,760 | +$160,530 | $0.20 | 26 |
| 2022 Q1 | 4,686,236 | $1,664,124 | -$605,100 | $0.36 | 20 |
| 2021 Q4 | 6,342,589 | $2,485,448 | +$148,773 | $0.39 | 31 |
| 2021 Q3 | 6,174,558 | $3,448,914 | -$4,397,135 | $0.56 | 34 |
| 2021 Q2 | 11,509,971 | $25,952,620 | +$11,191,349 | $2.31 | 39 |
| 2021 Q1 | 7,972,838 | $11,188,538 | +$2,089,935 | $1.41 | 44 |
| 2020 Q4 | 6,982,600 | $6,904,000 | +$987,728 | $0.99 | 18 |
| 2020 Q3 | 4,974,159 | $5,222,000 | -$1,417,580 | $1.05 | 11 |
| 2020 Q2 | 6,157,552 | $7,327,000 | -$4,519,773 | $1.19 | 9 |
| 2020 Q1 | 7,036,339 | $19,069,000 | -$20,968 | $2.71 | 14 |
| 2019 Q4 | 7,066,427 | $31,799,000 | -$3,824,500 | $4.50 | 13 |
| 2019 Q3 | 5,976,908 | $34,616,000 | -$644,221 | $5.90 | 18 |
| 2019 Q2 | 6,085,777 | $41,871,000 | +$217,627 | $6.88 | 18 |
| 2019 Q1 | 6,053,922 | $48,078,000 | -$1,661,911 | $8.03 | 18 |
| 2018 Q4 | 6,298,288 | $31,554,000 | -$256,026 | $5.01 | 20 |
| 2018 Q3 | 4,807,995 | $31,954,000 | -$2,675,606 | $6.70 | 19 |
| 2018 Q2 | 5,105,946 | $55,200,000 | +$55,200,111 | $10.89 | 22 |